高視醫療(02407.HK)內部職務調動 主席高鐵塔卸任行政總裁
高視醫療(02407.HK)公布,自昨日(25日)起,劉新偉獲委任為新任行政總裁,同日起不再擔任聯席行政總裁。作為執行董事兼行政總裁,劉新偉負責集團的整體營運及管理,參與擬定經營計劃及年度目標,帶領集團達成年度目標。
同日起,由於集團內部職務調動,高鐵塔不再擔任行政總裁,仍擔任執行董事兼董事會主席,將負責集團的整體策略發展,監督集團的整體營運及管理,並參與投資計劃及年度業務目標擬定等重大事項的決策。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.